Stay updated on Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page.

Latest updates to the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page now displays a new Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check15 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedAdded Revision: v3.4.2 to the site and removed the previous Revision: v3.4.1 along with the government funding operating-status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check51 days agoChange DetectedA site-wide funding notice banner was added, informing users that information may not be up to date and directing to cc.nih.gov and opm.gov for updates. The page also shows a minor revision note: Revision: v3.4.1 replaces v3.4.0.SummaryDifference0.3%

- Check58 days agoChange DetectedUI and documentation updates: glossary now shown; labeling updated for QC criteria submission and FEAR Act data; site revision tag updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page.